Mark E. Hatley
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Sarcoma Diagnosis and Treatment
Papers in
-
- Circular RNAs in diseases 2
- Cancer-related gene regulation 2
-
- Sarcoma Diagnosis and Treatment 11
- Co-authors
- Rene L. Galindo (2 shared papers)David Finkelstein (7 shared papers)Matthew R. Garcia (7 shared papers)Alfred G. Gilman (3 shared papers)Scott K. Gibson (1 shared paper)Rama Ranganathan (1 shared paper)Steve W. Lockless (1 shared paper)Jason A. Hanna (6 shared papers)
- Journals
- Cancer Cell (2 papers)Pediatric Blood & Cancer (1 paper)Nature reviews. Cancer (1 paper)Cell Death and Disease (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesNew Zealand
In The Last Decade
Mark E. Hatley
18 papers receiving 632 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 173
- Pulmonary and Respiratory Medicine 264
- Molecular Biology 441
- Pathology and Forensic Medicine 66
- Oncology 94
Countries citing papers authored by Mark E. Hatley
This map shows the geographic impact of Mark E. Hatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Hatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Hatley more than expected).
Fields of papers citing papers by Mark E. Hatley
This network shows the impact of papers produced by Mark E. Hatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Hatley. The network helps show where Mark E. Hatley may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Hatley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 111 | |
| 2 | 2012 | 94 | |
| 3 | 2015 | 88 | |
| 4 | 2014 | 78 | |
| 5 | 2015 | 63 | |
| 6 | 2018 | 59 | |
| 7 | 2018 | 37 | |
| 8 | 2016 | 31 | |
| 9 | 2000 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 1995 | 10 | |
| 13 | 2018 | 7 | |
| 14 | 2022 | 6 | |
| 15 | 2002 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 2021 | 1 | |
| 18 | 2021 | 1 |
About Mark E. Hatley
Mark E. Hatley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 18 papers that have together received 635 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Cancer-related molecular mechanisms research (4 papers), Tumors and Oncological Cases (3 papers), MicroRNA in disease regulation (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Circular RNAs in diseases (2 papers), Cardiac tumors and thrombi (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (173 citations), Pulmonary and Respiratory Medicine (264 citations), Molecular Biology (441 citations), Pathology and Forensic Medicine (66 citations) and Oncology (94 citations). Mark E. Hatley has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Rene L. Galindo, David Finkelstein, Matthew R. Garcia, Alfred G. Gilman, Scott K. Gibson, Rama Ranganathan, Steve W. Lockless, Jason A. Hanna, Catherine J. Drummond and Jerold E. Rehg. Their work appears in journals such as Cancer Cell, Pediatric Blood & Cancer, Nature reviews. Cancer, Cell Death and Disease and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.